#LCSM Chat Topic 3/23: What Is a High-Value Cancer Drug?
Our topic for the next #LCSM Chat on Thursday, March 23 at 5 PM Pacific (8 PM Eastern) will be “What Is a High-Value Cancer Drug?” With the price of new cancer drugs escalating, many are concerned about whether patients and the healthcare system can continue to access the most effective drugs. The 2016-2017 President’s Cancer Panel (PCP) topic is “Ensuring Patients’ Access to High-Value Cancer Drugs.” Andrew Schorr of Patient Power will be one of the patient advocates participating in the March 27, 2017 PCP meeting. This chat will help provide some inputs… Read More
#LCSM Chat Topic 3/9: Test Tumors to Target Lung Cancer
Our topic for the next #LCSM Chat on Thursday, March 9th at 5 PM Pacific (8 PM Eastern) is “Test Tumors to Target Lung Cancer.” Lung cancer treatments are evolving rapidly. Some newer treatments require testing to identify patients who are likely to respond to the drugs. The testing looks for certain biomarkers on the patient’s cancer tumors, like alterations in the tumor cells’ genes. Patients whose tumors test positive may be able to take approved targeted therapy drugs that are usually more effective and more tolerable than chemo. A substantial percentage… Read More
#LCSM Chat topic 11/17– FB Live Q&A with NCI on Immunotherapy and Clinical Trials
For Lung Cancer Awareness Month, the National Cancer Institute (NCI) is once again partnering with #LCSM Chat for a special event. During the first half of our November 17 tweetchat, which starts at the usual 8 PM Eastern time (5 PM Pacific), the NCI’s Dr. Shakun Malik (head of thoracic oncology therapeutics) and Janet Freeman-Daily (lung cancer patient/activist and founding member of #LCSM Chat) will have a 30-minute Facebook Live question and answer session on the topic of “Immunotherapy for Lung Cancer: New Research and Clinical Trials.” The Facebook Live event will… Read More
#LCSM 
You must be logged in to post a comment.